Survey and Research Archives | Page 22 of 145 | Be Korea-savvy

Archive by category Survey and Research

Bitget’s July Report Shows $461M Net Inflows and 100K New Copy Trading Users

Bitget’s July Report Shows $461M Net Inflows and 100K New Copy Trading Users

VICTORIA, Seychelles, Aug. 14, 2025 (Korea Bizwire) – Bitget, the world’s leading cryptocurrency exchange and Web3 company, ended July with another month of strong growth and global brand expansion. The platform maintained its CoinGecko Spot ranking as the 3rd largest crypto exchange, aligned with its consistently growing market presence. In July, Bitget showed steady growth across [...]

US Firm Achieves Second Thorium Breakthrough at Idaho National Lab’s Reactor

US Firm Achieves Second Thorium Breakthrough at Idaho National Lab’s Reactor

CCTE’s first-of-its-kind, thorium-based fuel continues to surpass burnup records, paving the way for safer and more sustainable nuclear power CHICAGO, Aug. 14, 2025 (Korea Bizwire) –  Clean Core Thorium Energy (CCTE) announces the second major milestone for its patented Advanced Nuclear Energy for Enriched Life (ANEEL™) fuel, which has now reached a burnup level of over 45 gigawatt-days [...]

ThreatLocker Chosen for 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies

ThreatLocker Chosen for 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies

Orlando, Florida, Aug. 12, 2025 (Korea Bizwire) – ThreatLocker® today announced its inclusion on the annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America.   In addition to ranking in the top 8% on the national list, ThreatLocker is No. 7 in the Orlando metro area, No. 47 in the state [...]

U.S. FDA grants accelerated approval to Boehringer’s HERNEXEOS® as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC

U.S. FDA grants accelerated approval to Boehringer’s HERNEXEOS® as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC

This press release is not intended for UK media.  HERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 75% (N=71), as demonstrated in the Beamion-LUNG 1 clinical trial1  Accelerated approval follows Priority Review and Breakthrough Therapy Designation granted by the U.S. FDA for the treatment of patients with HER2 (ERBB2)-mutant advanced non-small cell [...]

The Go-No-Go (GNG) Machine is Named by DUPR, Pickleballtournaments.com and The UPA-A as the Official and Exclusive On-Site Deflection Testing Device for Professional and Amateur Tours Across the Globe

The Go-No-Go (GNG) Machine is Named by DUPR, Pickleballtournaments.com and The UPA-A as the Official and Exclusive On-Site Deflection Testing Device for Professional and Amateur Tours Across the Globe

BOCA RATON, Fla., Aug. 08, 2025 (Korea Bizwire) – The Go-No-Go (GNG) Machine has been officially named the exclusive on-site paddle deflection testing device for professional and amateur pickleball by three major platforms: Dynamic Universal Pickleball Rating (DUPR), the United Pickleball Association of America (UPA-A), and Pickleballtournaments.com .This designation marks a pivotal advancement in the [...]

First LLM with Infinite Context Attention is here, wiping out $1.2 billion RAG market value by allowing AI to live outside the Matrix

First LLM with Infinite Context Attention is here, wiping out $1.2 billion RAG market value by allowing AI to live outside the Matrix

SAN FRANCISCO, Aug. 07, 2025 (Korea Bizwire) – Silicon Valley startup, iFrame™ AI, has quietly secured a nearly $20 million deal with a leading cloud provider to launch the world’s first Large Attention Model with an infinite context window – a breakthrough poised to disrupt the professional services industry and undercut OpenAI-like companies’ revenue from costly, [...]

Boehringer and Click Therapeutics’ investigational prescription digital therapeutic CT-155 meets primary endpoint in CONVOKE study for negative symptoms in schizophrenia

Boehringer and Click Therapeutics’ investigational prescription digital therapeutic CT-155 meets primary endpoint in CONVOKE study for negative symptoms in schizophrenia

CT-155 showed a reduction in experiential negative symptoms as an adjunct to standard of care antipsychotic therapy from baseline to week 16, as measured by CAINS-MAP. CT-155 is an investigational prescription digital therapeutic being evaluated to target negative symptoms of schizophrenia in a registrational randomized clinical trial.1,2 Often underappreciated and less recognized, negative symptoms impact [...]

LambdaTest Becomes First Platform to Launch Appium 3 Beta Support for Cloud-Based Mobile Testing

LambdaTest Becomes First Platform to Launch Appium 3 Beta Support for Cloud-Based Mobile Testing

It enables developers and testers to leverage Appium 3.0.0-rc.1 on the cloud with no local setup, enhanced speed, and robust CI/CD compatibility San Francisco, CA, Aug. 05, 2025 (Korea Bizwire) – LambdaTest, a GenAI-native quality engineering platform, has announced an industry-first integration of Appium 3.0.0-rc.1 (Beta), enabling users to run mobile test automation on Android and iOS [...]

TMC Releases Two Economic Studies with Combined NPV of $23.6B and Declares World-First Nodule Reserves

TMC Releases Two Economic Studies with Combined NPV of $23.6B and Declares World-First Nodule Reserves

TMC published two technical economic assessments prepared in accordance with Subpart 1300 of Regulation S-K highlighting a total combined project value of $23.6 billion, showing potential economic viability of its NORI-D Project and significant scalability across other NORI and TOML areas  World-first Pre-Feasibility Study (PFS) for a polymetallic nodule project in the NORI-D area with [...]

Young, Certified, and Winners: Pearson’s Certiport Announces 2025 Microsoft Office Specialist World Champions

Young, Certified, and Winners: Pearson’s Certiport Announces 2025 Microsoft Office Specialist World Champions

ORLANDO, Fla., July 30, 2025 (Korea Bizwire) – Pearson is proud to recognize the winners of the 2025 Microsoft Office Specialist (MOS) World Championship, announced by Certiport, a Pearson VUE business, and the leading provider of performance-based IT certification exams that accelerate academic and career opportunities for learners. Now in its 23rd year, the annual competition challenges students [...]